Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/135343
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Morrissey, Ian | - |
dc.contributor.author | Cantón, Rafael | - |
dc.contributor.author | Vila Estapé, Jordi | - |
dc.contributor.author | Gargallo Viola, Domingo | - |
dc.contributor.author | Zsolt, Ilonka | - |
dc.contributor.author | García Castillo, María | - |
dc.contributor.author | López, Yuly | - |
dc.date.accessioned | 2019-06-18T15:22:25Z | - |
dc.date.available | 2019-06-18T15:22:25Z | - |
dc.date.issued | 2019-05-28 | - |
dc.identifier.issn | 1746-0913 | - |
dc.identifier.uri | http://hdl.handle.net/2445/135343 | - |
dc.description.abstract | Aim: To explore the antibacterial spectrum of ozenoxacin and compare its in vitro activity with that of other antibacterial agents. Materials & methods: In 2010, 10,054 isolates were collected from 128 centers worldwide. Minimum inhibitory concentrations against Gram-positive and Gram-negative isolates were determined for 23 and 13 antibacterial agents, respectively. Results: Ozenoxacin exhibited high in vitro activity against susceptible, and methicillin- or levofloxacin-resistant, Gram-positive bacteria. Ozenoxacin was one or two dilutions less active against Enterobacteriaceae isolates, except for Escherichia coli, than other quinolones. Conclusion: Ozenoxacin is a potent antimicrobial agent mainly against susceptible and resistant strains of Gram-positive isolates (staphylococci and streptococci), and shows activity against some Gram-negative isolates. | - |
dc.format.extent | 15 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Future Science Group | - |
dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.2217/fmb-2019-0089 | - |
dc.relation.ispartof | Future Microbiology, 2019 | - |
dc.relation.uri | http://dx.doi.org/ 10.2217/fmb-2019-0089 | - |
dc.rights | cc by-nc-nd (c) Morrissey et al., 2019 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | - |
dc.source | Articles publicats en revistes (ISGlobal) | - |
dc.subject.classification | Infeccions respiratòries | - |
dc.subject.classification | Antibiòtics | - |
dc.subject.other | Respiratory infections | - |
dc.subject.other | Antibiotics | - |
dc.title | Microbiological profile of ozenoxacin | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2019-06-14T09:57:25Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MorrisseyI_Future_Microbiol_2019.pdf | 1.33 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License